Predictive Oncology Inc.

NASDAQ: POAI · Real-Time Price · USD
0.84
-0.03 (-3.45%)
At close: Aug 15, 2025, 12:54 PM

Predictive Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.62M 1.78M 1.51M 1.42M
Cost of Revenue
826.14K 634.8K 505.11K 487.02K
Gross Profit
797.68K 1.15M 1M 933.66K
Operating Income
-10.94M -14.08M -26.03M -13.47M
Interest Income
n/a n/a n/a n/a
Pretax Income
-10.86M -13.98M -25.74M -20.32M
Net Income
-12.2M -13.98M -25.74M -19.66M
Selling & General & Admin
8.89M 13.14M 12.47M 11.71M
Research & Development
25.99K 122.31K 320.32K 315.85K
Other Expenses
2.83M -122.31K 14.24M 9.34M
Operating Expenses
11.74M 13.14M 27.03M 21.36M
Interest Expense
n/a n/a 10.65M n/a
Selling & Marketing Expenses
1.47M 1.49M 1.36M 774.53K
Cost & Expenses
12.56M 15.86M 16.77M 14.89M
Income Tax Expense
n/a n/a 10.47M -661.66K
Shares Outstanding (Basic)
5.45M 4.01M 3.69M 2.73M
Shares Outstanding (Diluted)
5.45M 4.01M 3.69M 2.74M
EPS (Basic)
-2.24 -3.48 -6.98 -7.16
EPS (Diluted)
-2.24 -3.48 -6.98 -7.2
EBITDA
-10.24M -13.18M -13.95M -12.13M
EBIT
-10.94M -13.92M -15.27M -13.47M
Depreciation & Amortization
695.66K 739.32K 1.31M 1.34M